Get the Stockscreener App
11.00
3.17%
-0.36
Pre-market:
10.87
-0.13
-1.18%
Briacell Therapeutics Corp stock is traded at $11.00, with a volume of 40,108.
It is down -3.17% in the last 24 hours and up +0.00% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$11.36
Open:
$11.36
24h Volume:
40,108
Relative Volume:
0.15
Market Cap:
$20.72M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.2488
EPS:
-44.2199
Net Cash Flow:
$-28.59M
1W Performance:
-20.23%
1M Performance:
+0.00%
6M Performance:
+146.64%
1Y Performance:
-9.82%
1-Day Range:
$10.81
$11.57
1-Week Range:
$10.81
$13.90
52-Week Range:
$0.61
$19.05
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
11.00 | 21.40M | 0 | -26.56M | -28.59M | -44.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Is BriaCell Therapeutics Corp. Equity Warrant stock positioned for digital transformation2025 Analyst Calls & Safe Entry Point Identification - newser.com
Tools to monitor BriaCell Therapeutics Corp. recovery probabilityTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Forecasting BriaCell Therapeutics Corp. price range with options dataMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com
Can a trend reversal in BriaCell Therapeutics Corp. lead to recoveryPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
Will BriaCell Therapeutics Corp. Equity Warrant benefit from macro trendsJuly 2025 Trends & AI Based Buy/Sell Signal Reports - newser.com
(BCT) Financial Trading Report (BCT:CA) - news.stocktradersdaily.com
Applying Elliott Wave Theory to BriaCell Therapeutics Corp. Equity WarrantTrade Risk Report & Safe Entry Point Identification - newser.com
What MACD and RSI say about BriaCell Therapeutics Corp.July 2025 Update & High Yield Stock Recommendations - newser.com
Should I hold or sell BriaCell Therapeutics Corp. stock in 2025Jobs Report & High Win Rate Trade Alerts - newser.com
Is BriaCell Therapeutics Corp. stock attractive for growth ETFsRisk Management & Daily Profit Focused Screening - newser.com
Will BriaCell Therapeutics Corp. (8BT0) stock outperform energy sector in 2025Weekly Stock Recap & Weekly High Momentum Picks - newser.com
What indicators show strength in BriaCell Therapeutics Corp. Equity WarrantMarket Risk Analysis & Verified High Yield Trade Plans - newser.com
Why BriaCell Therapeutics Corp. Equity Warrant stock is trending among retail tradersJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Can you recover from losses in BriaCell Therapeutics Corp.July 2025 Summary & Safe Capital Preservation Plans - newser.com
What drives BriaCell Therapeutics Corp Equity Warrant stock priceCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
How to interpret RSI for BriaCell Therapeutics Corp. Equity Warrant stockMarket Weekly Review & Weekly Momentum Picks - newser.com
Quantitative breakdown of BriaCell Therapeutics Corp. Equity Warrant recent moveJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Order flow analysis tools used on BriaCell Therapeutics Corp.July 2025 Trends & AI Based Buy/Sell Signal Reports - newser.com
Is BriaCell Therapeutics Corp. Equity Warrant stock cheap at current valuationTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
Can BriaCell Therapeutics Corp. Equity Warrant recover in the next quarterWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
Best data tools to analyze BriaCell Therapeutics Corp. Equity Warrant stock2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Will BriaCell Therapeutics Corp. (8BT0) stock announce a stock splitPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Is a relief rally coming for BriaCell Therapeutics Corp. holders2025 Year in Review & Free Community Consensus Stock Picks - newser.com
Is BriaCell Therapeutics Corp. Equity Warrant stock overvalued by current metricsDay Trade & Capital Efficiency Focused Strategies - newser.com
Analyzing net buyer seller activity in BriaCell Therapeutics Corp. Equity WarrantFed Meeting & Growth Focused Stock Pick Reports - newser.com
Can BriaCell Therapeutics Corp. stock continue upward trendRecession Risk & Weekly High Potential Alerts - newser.com
Long term hold vs stop loss in BriaCell Therapeutics Corp. Equity WarrantQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Why BriaCell Therapeutics Corp. Equity Warrant stock is popular among millennials2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com
Is BriaCell Therapeutics Corp. a candidate for recovery play2025 Macro Impact & Low Drawdown Investment Strategies - newser.com
How BriaCell Therapeutics Corp. Equity Warrant stock performs in high volatility markets2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):